Source link : https://www.newshealth.biz/health-news/pcsk9-inhibitors-linked-to-lower-skin-cancer-risk-in-study/
TOPLINE: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, lipid-lowering drugs, were associated with a 22% lower risk for nonmelanoma skin cancer (NMSC) in patients with atherosclerotic cardiovascular disease (ASCVD), an effect that was particularly significant among men, those older than 65 years, and those with immunosuppression. METHODOLOGY: To evaluate the risk for NMSC — basal […]
Author : News Health
Publish date : 2024-12-06 10:59:43
Copyright for syndicated content belongs to the linked Source.